5 September 8:30 p.m., California
The global market for Digital Therapeutics (DTx) is projected to reach US$1.0 billion by 2025 driven by strong adoption of digital platforms like smartphones, apps, electronic wearables, mobile internet; growing focus on value based care; and rising venture capital investments in digital health based business models. DTx involves the use of online technology platforms such as mHealth tools; medical sensors; electronic medical wearables; artificial intelligence (IT); telehealth & wireless communication platforms; smartphones, apps and mobile internet, to offer medical care. The goal of DTx is to induce behavioral and lifestyle changes that positively influence disease treatment outcomes. Benefits of digital therapeutics driving its importance in the healthcare industry include the promise of overcoming the limitation of current primary care by providing timely and proactive care, reducing..
Alternatives to Face-to-Face Consultations is the Need of the Hour to Reduce the Growing Waiting List of Patients Pushed to the Sidelines During this COVID-19 War
17 Setember 6:30 p.m., California
The Pandemic Removes All Barriers to Digital Healthcare Including Patient Behavior. Market to Race Ahead With an18.8% CAGR The global Digital Health market is expected to witness a 37.1% spike in growth in the year 2021 and thereafter will continue to grow and reach US$508.8 billion by the year 2027, trailing a post COVID-19 CAGR of 18.8% over the analysis period 2020 through 2027. Non-COVID-19 healthcare has massively migrated to digital platforms over the last 8 months. From telemedicine to remote patient monitoring & management, new service delivery platforms have been adopted at lightning speeds. With the only available defense against COVID-19 being personal hygiene & mass physical distancing, digital technologies are coming into the spotlight to bridge the forced physical divide between doctor & patients. In several countries worldwide, searches for "Doctor near me" declined by..